Deal supported by Xplico

Roche and Inovio Pharmaceuticals partner on Inovio’s prostate cancer and hepatitis B immunotherapy products

By |September, 2013|Categories: Deal flow|0 Comments

Deal supported by Xplico

Novavax Announces Public Offer for All Outstanding Shares of Isconova

By |June, 2013|Categories: Deal flow|0 Comments

Deal supported by Xplico

4SC Discovery and LEO Pharma announce exclusive research and license agreement for inflammatory skin diseases

By |February, 2013|Categories: Deal flow|0 Comments